EUVIMEDEUVIMED entdecken
Crossref

Eliminating remnant CA 19-9 half-life-dependent antigen: An innovative approach for a more accurate interpretation of tumour marker follow-up

Peter Oehr

Open Journal of Clinical and Medical Case Reports · 2023

DOI: 10.52768/2379-1039/1967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Journal of Clinical and Medical Case Reports, 2023. Verfasst von Peter Oehr.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives: Tumour markers provide insights into the course of disease and response to therapy in carcinoma patients, allowing physicians to determine changes in marker levels during disease. We aimed to evaluate the value of newly produced CA 19 9 levels in determining the response to treatment and prognosi in patients with pancreatic adenocarcinoma.

Zitieren

APA

Oehr, P. (2023). Eliminating remnant CA 19-9 half-life-dependent antigen: An innovative approach for a more accurate interpretation of tumour marker follow-up. Open Journal of Clinical and Medical Case Reports. https://doi.org/10.52768/2379-1039/1967

Vancouver

Oehr P. Eliminating remnant CA 19-9 half-life-dependent antigen: An innovative approach for a more accurate interpretation of tumour marker follow-up. Open Journal of Clinical and Medical Case Reports. 2023. doi:10.52768/2379-1039/1967

BibTeX
@article{Oehr2023,
  author = {Oehr, Peter},
  title = {Eliminating remnant CA 19-9 half-life-dependent antigen: An innovative approach for a more accurate interpretation of tumour marker follow-up},
  journal = {Open Journal of Clinical and Medical Case Reports},
  year = {2023},
  doi = {10.52768/2379-1039/1967}
}
Kostenlos starten →